The FDA approved Genentech drug Xeloda (capecitabine)
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for the treatment of adjuvant colon cancer, metastatic colorectal cancer and metastatic breast cancer.
Tags:
Source: U.S. Food and Drug Administration
Credit:
